Skip to content

Clinical trials

Candidiasis, Invasive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis, Invasive Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20075
20081
20092
20131
20141
20151
20161
20172
20181
20201
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Scynexis, Inc.4
Astellas Pharma Inc3
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Duke University2
Arkansas Children's Hospital Research Institute1
Basilea Pharmaceutica1
CanXida1
Kevin Watt1
Mundipharma Research Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis, Invasive22
Candidemia16
Candidiasis9
Mycoses7
Fungemia4
Invasive Fungal Infections2
Pathologic Processes2
Sepsis2
Systemic Inflammatory Response Syndrome2
Aspergillosis, Allergic Bronchopulmonary1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.